Show simple item record

dc.contributor.authorSandbergen, Laura
dc.contributor.authorSpriensma, Alette Sigrid
dc.contributor.authorde la Rosette, Jean J. M. C. H.
dc.contributor.authorLaguna, María Pilar
dc.date.accessioned2020-01-23T14:02:19Z
dc.date.available2020-01-23T14:02:19Z
dc.date.issued2020en_US
dc.identifier.citationSandbergen, L., Spriensma, A. S., de la Rosette, J. J. M. C. H. ve Laguna, M. P. (2020). Health-related quality of life in localized renal masses: A matter of sparing nephrons or minimizing the incision? Urologic Oncology-Seminars and Original Investigations, 38(2), 43.e1-43.e11. https://doi.org/10.1016/j.urolonc.2019.09.017en_US
dc.identifier.issn1078-1439
dc.identifier.issn1873-2496
dc.identifier.urihttps://doi.org/10.1016/j.urolonc.2019.09.017
dc.identifier.urihttps://hdl.handle.net/20.500.12511/4924
dc.description.abstractPurpose: Longitudinal assessment of health-related quality of life (HRQoL) differences in patients with localized renal masses according to treatment strategy. Methods: Consecutive patients >= 18 years with localized renal masses treated with different approaches (open [O], laparoscopic [L], and percutaneous [P]) and modalities (radical nephrectomy [RN], nephron sparing surgery [NSS] and cryoablation [CA]). The SF-36, Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 questionnaires and pain visual analog scale were completed pretreatment and at 1, 3, and 12 months posttreatment. Questionnaire results were stratified according to approach and treatment modality using a longitudinal multilevel linear regression model. Clinical patient and tumor characteristics, complications, and histopathology results were tested as confounders. Results: Ninety eight patients completed baseline and at least one follow-up questionnaires; 27.5%, 16.3%, 22.5%, 9.2%, 13.3%, and 11.2% patients received LNSS, ONSS, LRN, ORN, LCA, and PCA, respectively. Higher baseline SF-36 (3 domains) and Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 scores were reported in L group compared with the O approach. Overall, HRQoL decreased at 1 month and gradually normalized to baseline level or higher at 1 year. For treatment modality at baseline, higher mean visual analog scale was observed in CA than RN group. A trend to decreased HRQoL was observed at 1 month for RN and NSS; thereafter, scores normalized to baseline levels or higher. Approach or treatment modality HRQoL did not change substantially when corrected for confounders. Conclusion: At short-term, HRQoL outcome favored minimally invasive treatment of RCC; at mid-term, these advantages were no longer apparent. This suggest that in selecting the best surgical treatment for the patient, oncological outcome should be the primary consideration as both approach and treatment modality result in similar HRQoL outcomes. (C) 2019 Elsevier Inc. All rights reserved.en_US
dc.language.isoengen_US
dc.publisherElsevier Science Incen_US
dc.rightsinfo:eu-repo/semantics/embargoedAccessen_US
dc.subjectHealth-Related Quality of Lifeen_US
dc.subjectLocalized Renal Massen_US
dc.subjectInterventionen_US
dc.subjectQuality of Life Questionnaireen_US
dc.titleHealth-related quality of life in localized renal masses: A matter of sparing nephrons or minimizing the incision?en_US
dc.typearticleen_US
dc.relation.journalUrologic Oncology-Seminars and Original Investigationsen_US
dc.departmentİstanbul Medipol Üniversitesi, Uluslararası Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Üroloji Ana Bilim Dalıen_US
dc.identifier.volume38en_US
dc.identifier.issue2en_US
dc.identifier.startpage43.e1en_US
dc.identifier.endpage43.e11en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.doi10.1016/j.urolonc.2019.09.017en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record